In an Oct. 9 press release, the BMGF announced that the $40 million will be utilized to "advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries' capacity to develop high-quality, lifesaving vaccines at scale." It argued that mRNA vaccines have "simpler research and manufacturing processes" compared to traditional counterparts, enabling the development of low-cost injections against diseases like malaria and tuberculosis.
According to the foundation, $20 million will be earmarked for Belgium-based Quantoom Biosciences to further improve the mRNA platform it developed. The Pasteur Institute of Dakar (IPD) located in Senegal and the South Africa-based Biovac will be receiving $5 million each. The remaining $10 million will go to vaccine manufacturers from low- and middle-income countries "to be named" in the future. (Related: MEDICAL MADNESS: Bill Gates developing new vaccine that claims to prevent polio caused by polio vaccines.)
The BMGF said Quantoom's platform can lead to a more than 50 percent drop in mRNA vaccine development costs compared to traditional mRNA technology. The $40 million funding adds to the foundation's $55 million in mRNA manufacturing technology.
"We welcome this new funding, which will promote the development of lifesaving technologies on the continent while also contributing to global health security by expanding the supply and access to vaccines – allowing us to achieve greater health equity worldwide," said IPD CEO Dr. Amadou Sall.
"This collaboration will help close critical gaps in access to promising mRNA vaccines against diseases that disproportionately affect the world's poorest," said Biovac CEO Morena Makhoana. "It will also assist us in our mission to establish end-to-end vaccine manufacturing capability at scale in Africa for global supply."
The BMGF's $40 million investment follows safety concerns surrounding mRNA technology, which was used for the Wuhan coronavirus (COVID-19) vaccines made by Pfizer and Moderna. During a September testimony before the European Parliament in Brussels, cardiologist Dr. Peter McCullough shared the "horrifying" things he has learned about mRNA injections.
"There's not a single study that the messenger RNA is broken down," he told European lawmakers, explaining that the mRNA is "made synthetically." McCullough continued: "There's not a study showing it leaves the body."
According to the Texas-based physician, the mRNA sequence used for the COVID-19 injection was copied from the SARS-CoV-2 spike protein – an element that made the pathogen deadly.
"We have the spike protein – the lethal protein from the [COVID-19] vaccines found in the human body after vaccination – circulating at least for six months, if not longer. If people take an injection in another six months, there's another installation in more circulating potentially lethal [spike] protein."
Also in September, Florida Surgeon General Dr. Joseph Ladapo advised people under 65 years old not to take the new COVID-19 mRNA vaccines granted emergency use authorization by the U.S. Food and Drug Administration. For those 65 years old and up, he advised them to discuss the risks of the COVID-19 mRNA vaccine with their doctor.
"There's essentially no evidence for it," said the Sunshine State's top physician during a news conference. "There's been no clinical trial done in human beings showing that it benefits people. There's been no clinical trial showing that it is a safe product for people."
Ladapo cited "multiple studies" from various countries to back up his advice against the COVID-19 injections. "Over time, these … mRNA COVID-19 products actually increase your chances of contracting COVID-19.
Head over to VaccineWars.com for more stories about the BMGF's efforts to fund vaccine development in Africa.
Watch this video about Bill Gates' involvement in the 2009 Gardasil vaccine trials in India.
This video is from the Sons of Single Moms channel on Brighteon.com.